News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,544 Results
Type
Article (575)
Company Profile (1)
Press Release (12968)
Section
Business (4214)
Career Advice (6)
Deals (834)
Drug Delivery (1)
Drug Development (1177)
Employer Resources (1)
FDA (244)
Job Trends (125)
News (5855)
Policy (501)
Tag
2027 Biotech Beach Standard (1)
Academia (31)
Alliances (1621)
ALS (2)
Alzheimer's disease (13)
Antibody-drug conjugate (ADC) (11)
Approvals (259)
Artificial intelligence (8)
ASCO (1)
Autoimmune disease (6)
Bankruptcy (2)
Belgium (1)
Best Places to Work (91)
Biosimilars (11)
BioSpace Insights (2)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (14)
Cancer (77)
Cardiovascular disease (3)
Career advice (5)
CAR-T (3)
CDMO (4)
Cell therapy (12)
Clinical research (1105)
Collaboration (57)
Commercialization (1)
Compensation (15)
COVID-19 (38)
CRISPR (1)
C-suite (26)
Cystic fibrosis (1)
Data (125)
Depression (3)
Diabetes (5)
Diagnostics (134)
Drug discovery (7)
Drug shortages (1)
Earnings (910)
Employer resources (1)
ESMO (7)
Events (1206)
Executive appointments (13)
FDA (303)
Funding (30)
Gene editing (2)
Gene therapy (9)
GLP-1 (10)
Government (28)
Guidances (5)
Healthcare (309)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (7)
Infectious disease (40)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (5)
Interviews (2)
IPO (207)
Job creations (34)
Job search strategy (4)
Kidney disease (6)
Labor market (2)
Layoffs (4)
Legal (150)
Licensing (1)
Liver cancer (1)
Lung cancer (9)
Lymphoma (2)
Management (1)
Manufacturing (19)
Medical device (187)
Medtech (191)
Melanoma (2)
Mergers & acquisitions (660)
Metabolic disorders (7)
mRNA (4)
Multiple sclerosis (6)
Netherlands (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (40)
NextGen: Class of 2026 (43)
Non-profit (6)
Obesity (2)
Ovarian cancer (1)
Pain (9)
Pancreatic cancer (1)
Parkinson's disease (5)
Patents (7)
Patient recruitment (16)
Patient selection (1)
People (859)
Peptides (1)
Pharmaceutical (1)
Phase 1 (342)
Phase 2 (474)
Phase 3 (385)
Pipeline (186)
Policy (2)
Postmarket research (41)
Preclinical (120)
Prostate cancer (5)
Radiopharmaceuticals (8)
Rare diseases (11)
Real estate (132)
Regulatory (408)
Reports (2)
Research institute (29)
Resumes & cover letters (1)
Schizophrenia (2)
Series A (8)
Series B (1)
Service/supplier (1)
Startups (89)
Supply chain (1)
Switzerland (1)
Vaccines (9)
Venture capital (2)
Date
Last 7 days (5)
Last 30 days (26)
Last 365 days (347)
2026 (316)
2025 (339)
2024 (456)
2023 (557)
2022 (1825)
2021 (1643)
2020 (1124)
2019 (752)
2018 (480)
2017 (651)
2016 (540)
2015 (765)
2014 (599)
2013 (505)
2012 (573)
2011 (508)
2010 (435)
Location
Africa (7)
Arizona (1)
Asia (622)
Australia (186)
California (84)
Canada (54)
China (7)
Connecticut (1)
Delaware (10)
Europe (5622)
Florida (9)
Georgia (3)
Idaho (1)
Illinois (21)
Indiana (1)
Japan (26)
Kentucky (1)
Maryland (7)
Massachusetts (84)
Michigan (9)
New Jersey (31)
New York (17)
North Carolina (12)
Northern California (63)
Pennsylvania (104)
Rhode Island (2)
South America (18)
Southern California (12)
Texas (8)
United States (415)
Utah (8)
Virginia (1)
Washington State (4)
Wisconsin (1)
13,544 Results for "jennewein biotechnologie gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a
September 22, 2020
·
4 min read
Jennewein Publishes New Results on the Norovirus-inhibiting Effect of Complex Oligosaccharides
Jennewein Biotechnologie GmbH announces the publication of the latest results from its norovirus research program in the Journal of Biotechnology.
May 27, 2020
·
3 min read
Jennewein Biotechnologie Develops New Fermentation Technology for Human Milk Oligosaccharides and Expands its Product Portfolio
Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis approach for the production of human milk oligosaccharides (HMOs).
September 19, 2018
·
2 min read
Policy
ITC Exclusion Order Now in Effect against Jennewein Biotechnologie GmbH
Glycosyn LLC, a pioneer in in the field of Human Milk Oligosaccharides (HMOs), which are prebiotics known to support a healthy gut microbiome, and which were previously found only in breast milk, announced today that the exclusion order issued by the
July 24, 2020
·
1 min read
Press Releases
LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
July 17, 2026
·
5 min read
Deals
Jennewein Biotechnologie GmbH Acquires Arthus Mineralsprings Bad Hönningen to Build a New Integrated Fermentation and Recovery Plant for Human Milk Oligosaccharides
RHEINBREITBACH, Germany, /PRNewswire/ -- Jennewein Biotechnologie GmbH announces that it has acquired the former facilities of Arthus Mineralspring Company in Bad Hönningen (Rhineland-Palatine) in order to expand the production of human milk oligosaccharides (HMOs).
October 8, 2018
·
1 min read
Press Releases
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
April 14, 2026
·
1 min read
Press Releases
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
April 29, 2026
·
5 min read
Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix
Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the “HMO-Mix.”
January 8, 2020
·
3 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
1 of 1,355
Next